MEI Pharma, Inc. (MEIP)
USD 2.52
(-3.45%)
USD 2.52
(-3.45%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 65.29 Million | 48.81 Million | 40.69 Million | 25.53 Million | 28.91 Million | 4.91 Million |
| Cost of Revenue | 15.97 Million | 1.81 Million | 1.23 Million | 1.4 Million | 2.67 Million | 4.26 Million |
| Gross Profit | 49.32 Million | 47 Million | 39.46 Million | 24.12 Million | 26.24 Million | 652 Thousand |
| Operating Expenses | 34.78 Million | 85.58 Million | 116.18 Million | 93.81 Million | 50.78 Million | 46.89 Million |
| Selling, General and Administrative Expenses | 23.29 Million | 33.13 Million | 30.54 Million | 24.41 Million | 16.71 Million | 14.59 Million |
| Research and Development Expenses | 16.56 Million | 52.45 Million | 85.64 Million | 69.39 Million | 34.06 Million | 32.3 Million |
| Other Expenses | -5.07 Million | -22 Thousand | -6000.00 | 486 Thousand | - | - |
| Cost and Expenses | 50.75 Million | 85.58 Million | 116.18 Million | 95.22 Million | 53.45 Million | 51.16 Million |
| Operating Income | 14.54 Million | -36.76 Million | -75.48 Million | -69.68 Million | -24.54 Million | -46.24 Million |
| Interest Expense | - | - | 284 Thousand | - | - | - |
| Income Tax Expense | - | -4.94 Million | 284 Thousand | 8000.00 | 1000.00 | 1000.00 |
| Earnings before Tax | 17.77 Million | -31.83 Million | -54.45 Million | -50.56 Million | -46.01 Million | -16.81 Million |
| Net Income | 17.77 Million | -31.84 Million | -54.45 Million | -41.31 Million | -47.17 Million | -16.81 Million |
| Earnings Per Share Basic | 2.67 | -4.78 | -8.75 | -7.40 | -10.40 | -4.73 |
| Earnings Per Share Diluted | 2.67 | -4.78 | -9.99 | -12.00 | -10.40 | -4.65 |
| Weighted Average Shares Outstanding | 6.66 Million | 6.66 Million | 6.22 Million | 5.63 Million | 4.55 Million | 3.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.66 Million | 6.66 Million | 6.26 Million | 5.72 Million | 4.55 Million | 3.61 Million |
| Gross Margin | 0.76 | 0.96 | 0.97 | 0.94 | 0.91 | 0.13 |
| EBIT Margin | 0.40 | -0.78 | -2.36 | -3.43 | -0.05 | -15.01 |
| Profit Margin | 0.27 | -0.65 | -1.35 | -1.98 | -1.59 | -3.42 |
| EBITDA | 26.38 Million | -36.76 Million | -75.15 Million | -60.13 Million | -25.58 Million | -46.16 Million |
| Earnings Before Tax Margin | 0.22 | -0.75 | -1.85 | -2.73 | -0.85 | -9.41 |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Revenue | 65.29 Million | - | - | - | 65.29 Million | 48.81 Million |
| Cost of Revenue | - | 3.77 Million | 86 Thousand | 85 Thousand | 459 Thousand | 1.81 Million |
| Gross Profit | 65.29 Million | -3.77 Million | -86 Thousand | -85 Thousand | 64.83 Million | 47 Million |
| Operating Expenses | 50.75 Million | 8.08 Million | 9.74 Million | 11.84 Million | 10.01 Million | 85.58 Million |
| Selling, General and Administrative Expenses | - | 4.13 Million | 4.52 Million | 7.93 Million | 6.53 Million | - |
| Research and Development Expenses | - | 3.94 Million | 5.22 Million | 3.91 Million | 3.48 Million | - |
| Other Expenses | 10.89 Million | -34 Thousand | -4000.00 | -2000.00 | -1000.00 | -22 Thousand |
| Cost and Expenses | 50.75 Million | 8.08 Million | 9.82 Million | 11.93 Million | 10.01 Million | 85.58 Million |
| Operating Income | 14.54 Million | -18.98 Million | -9.82 Million | -11.93 Million | 55.28 Million | -36.76 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | - | -608 Thousand | - | - | -1.09 Million | -4.94 Million |
| Earnings before Tax | 17.77 Million | -18.4 Million | -9.12 Million | -11.06 Million | 56.37 Million | -31.83 Million |
| Net Income | 17.77 Million | -18.41 Million | -9.13 Million | -11.06 Million | 56.37 Million | -31.83 Million |
| Earnings Per Share Basic | - | -2.76 | -1.37 | -1.66 | 8.46 | - |
| Earnings Per Share Diluted | - | -2.76 | -1.37 | -1.66 | 8.46 | - |
| Weighted Average Shares Outstanding | 6.66 Million | 6.66 Million | 6.66 Million | 6.66 Million | 6.66 Million | 6.66 Million |
| Weighted Average Shares Outstanding (Diluted) | 6.66 Million | 6.66 Million | 6.66 Million | 6.66 Million | 6.66 Million | 6.66 Million |
| Gross Margin | 1.00 | - | - | - | 0.99 | 0.96 |
| EBIT Margin | - | - | - | - | 0.85 | - |
| Profit Margin | 0.27 | - | - | - | 0.86 | -0.65 |
| EBITDA | - | -7.95 Million | -9.74 Million | -11.84 Million | 55.36 Million | - |
| Earnings Before Tax Margin | 0.22 | - | - | - | 0.85 | -0.75 |
6654
0280
TLGO
9733
FLFL
DHR